Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fecal microbiota transplant (Peking University Sixth Hospital)
- Development stage
- Unknown
- Lead developer
- Peking University Sixth Hospital
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Fecal microbiota transplant (FMT) is a live biotherapeutic product being investigated by Peking University Sixth Hospital for the treatment of chronic insomnia disorder. [5] The therapy involves transferring gut microbiota from healthy donors to patients to restore a healthy gut microbiome. [3] In a Phase 1/2 clinical trial (NCT05917379), the treatment is administered via oral capsules, with a control group receiving starch-filled placebo capsules. [7] The study aims to evaluate the efficacy of this approach on sleep status, with some patient groups also receiving synbiotics (a combination of probiotics and prebiotics). [7] The proposed mechanism involves modulating the gut-brain axis, as the gut microbiome is believed to play a role in regulating sleep. [2, 5]
- Other names
- fecal microbiota-Peking University Sixth Hospital-chronic insomnia disorderFMT
Beyond the preview
Go deeper on fecal microbiota transplant (Peking University Sixth Hospital).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fecal microbiota transplant (Peking University Sixth Hospital).